BOOK
Current Management Guidelines in Thoracic Surgery, An Issue of Thoracic Surgery Clinics - E-Book
(2012)
Additional Information
Book Details
Abstract
This issue highlights management issues surrounding specific subjects within the clinical practice of thoracic surgery. The articles represent areas of thoracic surgery where there may be controversy, lack of consensus, or evolution. Each author summarizes the available literature with the addition of his or her own personal expertise.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Current Management Guidelines in Thoracic Surgery | i | ||
| Copyright Page | ii | ||
| Table of Contents | v | ||
| Contributors | iii | ||
| Preface: Current Management Guidelines in Thoracic Surgery | xi | ||
| Chaptre 1. Perioperative\rSmoking Cessation | 1 | ||
| SMOKING CESSATION | 2 | ||
| CESSATION INTERVENTIONS | 3 | ||
| RECOMMENDATIONS AND BEST PRACTICES FOR SMOKING CESSATION | 9 | ||
| SUMMARY | 9 | ||
| REFERENCES | 10 | ||
| Chapter 2. Prophylaxis and Management of Atrial Fibrillation After General Thoracic Surgery | 13 | ||
| CAUSES AND RISK FACTORS | 13 | ||
| CONTINUATION OF PREOPERATIVE BETA BLOCKERS | 14 | ||
| CALCIUM-CHANNEL BLOCKER PROPHYLAXIS | 15 | ||
| AMIODARONE PROPHYLAXIS | 16 | ||
| BETA BLOCKER PROPHYLAXIS | 17 | ||
| MAGNESIUM PROPHYLAXIS | 17 | ||
| SUMMARY | 21 | ||
| REFERENCES | 21 | ||
| Chapter 3. Deep Vein Thrombosis/ Pulmonary Embolism: Prophylaxis, Diagnosis, and Management | 25 | ||
| DEEP VEIN THROMBOSIS | 25 | ||
| ACUTE PULMONARY EMBOLISM | 26 | ||
| SUMMARY | 27 | ||
| REFERENCES | 28 | ||
| Chapter 4. The Management of Anticoagulants Perioperatively | 29 | ||
| WARFARIN | 29 | ||
| THIENOPYRIDINES | 30 | ||
| HEPARIN | 32 | ||
| DABIGATRAN | 32 | ||
| OTHER ANTICOAGULANTS | 32 | ||
| DIPYRIDAMOLE | 32 | ||
| RESUMPTION OF ANTICOAGULANTS POSTOPERATIVELY | 32 | ||
| SUMMARY | 33 | ||
| REFERENCES | 33 | ||
| Chapter 5. Perioperative Antibiotics in Thoracic Surgery | 35 | ||
| DEFINITION OF SURGICAL SITE INFECTION | 35 | ||
| HISTORY OF SURGICAL ANTIBIOTIC PROPHYLAXIS | 35 | ||
| PRACTICE PATTERNS OF SURGICAL PROPHYLAXIS IN THORACIC SURGERY | 36 | ||
| SUMMARY | 43 | ||
| REFERENCES | 43 | ||
| Chapter 6. Physiologic Evaluation of Lung Resection Candidates | 47 | ||
| AGE | 48 | ||
| NUTRITION | 48 | ||
| CARDIOVASCULAR RISK | 48 | ||
| SURGEON SPECIALTY | 49 | ||
| PULMONARY FUNCTION TESTING | 49 | ||
| SPIROMETRY | 49 | ||
| TUMOR-RELATED ANATOMIC AND OTHER CONSIDERATIONS | 50 | ||
| CARDIOPULMONARY EXERCISE TESTING | 51 | ||
| STAIR CLIMBING | 51 | ||
| SIX-MINUTE WALK TEST/SHUTTLE-WALK TEST | 51 | ||
| ARTERIAL BLOOD GAS MEASUREMENTS | 52 | ||
| ADDITIONAL CONSIDERATIONS | 52 | ||
| SUMMARY | 52 | ||
| REFERENCES | 53 | ||
| Chapter 7. Management of Early Stage Non–Small Cell Lung Cancer in\rHigh-Risk Patients | 55 | ||
| SUBLOBAR RESECTION | 55 | ||
| RADIATION THERAPY | 58 | ||
| PERCUTANEOUS ABLATIVE THERAPIES | 60 | ||
| REFERENCES | 62 | ||
| Chapter 8. Induction Therapy for Lung Cancer: Sailing Across the Pillars of Hercules | 67 | ||
| A DECALOGUE ON INDUCTION TREATMENT IN 2011 | 68 | ||
| SUMMARY | 62 | ||
| REFERENCES | 73 | ||
| Chapter 9. Chest Wall Sarcomas\rand Induction Therapy | 77 | ||
| PATHOLOGY | 77 | ||
| CLINICAL EVALUATION | 77 | ||
| PRIMARY SOFT TISSUE SARCOMAS | 78 | ||
| PRIMARY SARCOMAS OF THE CHEST WALL: SOFT TISSUE | 78 | ||
| PRIMARY SARCOMAS OF THE CHEST WALL: CARTILAGE AND BONE | 79 | ||
| SPECIAL CONSIDERATIONS | 80 | ||
| SUMMARY | 80 | ||
| REFERENCES | 80 | ||
| Chapter 10. Induction Therapy for\rThymic Malignancies | 83 | ||
| SHOULD PATIENTS WITH STAGE III OR GREATER THYMIC MALIGNANCIES RECEIVE INDUCTION CHEMOTHERAPY OR RADIATION? | 83 | ||
| DISCUSSION | 85 | ||
| SUMMARY | 88 | ||
| REFERENCES | 88 | ||
| Chapter 11. Pulmonary Metastasectomy | 91 | ||
| RADIOGRAPHIC IMAGING | 92 | ||
| LYMPH NODE STATUS | 93 | ||
| CONSIDERATIONS FOR THE SURGICAL APPROACH | 94 | ||
| EXTENT OF SURGICAL RESECTION | 95 | ||
| SOME COMMON PULMONARY METASTASECTOMY TUMOR HISTOPATHOLOGIES | 96 | ||
| SUMMARY | 97 | ||
| REFERENCES | 97 | ||
| Chapter 12. Management of Barrett Esophagus with High-grade Dysplasia | 101 | ||
| DEFINITIONS | 101 | ||
| DIAGNOSIS | 102 | ||
| SURVEILLANCE | 103 | ||
| NATURAL HISTORY | 103 | ||
| MANAGEMENT OPTIONS | 104 | ||
| SUMMARY | 105 | ||
| REFERENCES | 106 | ||
| Chapter 13. Evidence-Based Review of the Management of Cancers of the Gastroesophageal Junction | 109 | ||
| STAGE I ESOPHAGEAL CANCER | 109 | ||
| CLINICAL T2N0M0 ESOPHAGEAL CANCER | 111 | ||
| CLINICAL N1 OR T3N0 ESOPHAGEAL CANCER | 112 | ||
| NEOADJUVANT CHEMORADIATION FOLLOWED BY SURGERY FOR LOCALLY ADVANCED ESOPHAGEAL CANCER | 115 | ||
| DEFINITIVE CHEMORADIATION FOR LOCALLY ADVANCED ESOPHAGEAL CANCER | 118 | ||
| SUMMARY | 119 | ||
| REFERENCES | 119 | ||
| Chapter 14. Follow-up of Patients with Resected Thoracic Malignancies | 123 | ||
| METHODS | 123 | ||
| NON–SMALL CELL LUNG CANCER | 124 | ||
| ESOPHAGEAL | 127 | ||
| THYMOMA | 128 | ||
| CHEST WALL TUMORS | 129 | ||
| MESOTHELIOMA | 129 | ||
| SUMMARY | 130 | ||
| REFERENCES | 130 | ||
| Index | 133 |